Biofrontera AG Sponsored ADR Net Cash/Marketcap

Net Cash/Marketcap of BFAGY for past 10 years: annual, quarterly and twelve month trailing (TTM) including Net Cash/Marketcap growth rates and interactive chart.


Highlights and Quick Summary

Current Net Cash/Marketcap of Biofrontera AG Sponsored ADR is $-0.0487 (as of December 31, 2021)
  • Net Cash/Marketcap for the quarter ending June 30, 2022 was $0.0004 (a -100.61% decrease compared to previous quarter)
  • Year-over-year quarterly Net Cash/Marketcap decreased by -100.82%
  • Annual Net Cash/Marketcap for 2021 was $-0.0487 (a -205.64% decrease from previous year)
  • Annual Net Cash/Marketcap for 2021 was $0.0461 (a -8.89% decrease from previous year)
  • Annual Net Cash/Marketcap for 2020 was $0.0506 (a -16.09% decrease from previous year)
Visit stockrow.com/BFAGY for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Net Cash/Marketcap of Biofrontera AG Sponsored ADR

Most recent Net Cash/Marketcapof BFAGY including historical data for past 10 years.

Interactive Chart of Net Cash/Marketcap of Biofrontera AG Sponsored ADR

Biofrontera AG Sponsored ADR Net Cash/Marketcap for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2022 $0.0 $0.0
2021 $0.0 $0.0 $0.0 $0.0 $0.0
2020 $0.0 $0.0 $0.0 $0.0 $0.0
2019 $0.0 $0.0 $0.0 $0.0
2018 $0.0 $0.0
2017 $0.0 $0.0 $0.0
2016 $0.0 $0.0

Business Profile of Biofrontera AG Sponsored ADR

Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic